Cost-effectiveness of a primary healthcare intervention to treat male lower urinary tract symptoms: the TRIUMPH cluster randomised controlled trial.

ABSTRACT:

Objectives

To estimate the cost-effectiveness of a primary care intervention for male lower urinary tract symptoms (LUTS) compared with usual care.

Design

Economic evaluation alongside a cluster randomised controlled trial from a UK National Health Service (NHS) perspective with a 12-month time horizon.

Setting

Thirty NHS general practice sites in England.

Participants

1077 men aged 18 or older identified in primary care with bothersome LUTS.

Interventions

A standardised and manualised intervention for the treatment of bothersome LUTS was compared with usual care. The intervention group (n=524) received a standardised information booklet with guidance on conservative treatment for LUTS, urinary symptom assessment and follow-up contacts for 12 weeks. The

SUBMITTER: Cochrane M 

PROVIDER: S-EPMC10828877 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature